- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 399-413 of
1,371 results
2055 Exhibit: JSN 2055 Scher et al, ¿¿¿Bicalutamide for Advanced Prostate Cancer ...
Document
IPR2016-01332, No. 2055-62 Exhibit - JSN 2055 Scher et al, ¿¿¿Bicalutamide for Advanced Prostate Cancer The Natural Versus Treated History of Disease,¿¿¿ (P.T.A.B. Mar. 8, 2017)
|
|
Cite Document
1140 Exhibit: Taxotere Label 2004
Document
IPR2016-01332, No. 1140-199 Exhibit - Taxotere Label 2004 (P.T.A.B. Apr. 19, 2017)
|
|
Cite Document
1131 Exhibit: US Patent No 8,183,274
Document
IPR2016-01332, No. 1131-194 Exhibit - US Patent No 8,183,274 (P.T.A.B. Apr. 19, 2017)
|
|
Cite Document
2021 Exhibit: JSN 2021 Boumpas et al, ¿¿¿Glucocorticoid Therapy for Immune medi...
Document
IPR2016-01332, No. 2021-27 Exhibit - JSN 2021 Boumpas et al, ¿¿¿Glucocorticoid Therapy for Immune mediated Diseases Basic and Clinical Correlates,¿¿¿ (P.T.A.B. Mar. 8, 2017)
|
|
Cite Document
1006 Exhibit: Tannock 1996
Document
IPR2016-01332, No. 1006 Exhibit - Tannock 1996 (P.T.A.B. Jun. 30, 2016)
|
|
Cite Document
1095 Exhibit: COUAAOO1 Synopsis from Clinicaltrialsgov
Document
IPR2016-01332, No. 1095-163 Exhibit - COUAAOO1 Synopsis from Clinicaltrialsgov (P.T.A.B. Apr. 19, 2017)
|
|
Cite Document
1125 Exhibit: FDA Prostate Cancer Endpoints Workshop
Document
IPR2016-01332, No. 1125-191 Exhibit - FDA Prostate Cancer Endpoints Workshop (P.T.A.B. Apr. 19, 2017)
|
|
Cite Document
1105 Exhibit: Garnick 1989
Document
IPR2016-01332, No. 1105-171 Exhibit - Garnick 1989 (P.T.A.B. Apr. 19, 2017)
|
|
Cite Document
1130 Exhibit: US Patent No 7,709,517
Document
IPR2016-01332, No. 1130-193 Exhibit - US Patent No 7,709,517 (P.T.A.B. Apr. 19, 2017)
|
|
Cite Document
2060 Exhibit: JSN 2060 Marini et al, ¿¿¿The effect of adjuvant prednisone combined ...
Document
IPR2016-01332, No. 2060-67 Exhibit - JSN 2060 Marini et al, ¿¿¿The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients w...
|
|
Cite Document
2014 Exhibit: JSN 2014 Attard et al, ¿¿¿Phase I Clinical Trial of a Selective Inhibitor o...
Document
IPR2016-01332, No. 2014-20 Exhibit - JSN 2014 Attard et al, ¿¿¿Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate (P.T.A.B. Mar. 8, 2017)
|
|
Cite Document
1029 Exhibit: 977 Patent
Document
IPR2016-01332, No. 1029 Exhibit - 977 Patent (P.T.A.B. Jun. 30, 2016)
|
|
Cite Document
1149 Exhibit: Donovan Email 3 9 17
Document
IPR2016-01332, No. 1149-224 Exhibit - Donovan Email 3 9 17 (P.T.A.B. May. 3, 2017)
|
|
Cite Document
2052 Exhibit: JSN 2052 Grinspoon and Biller, ¿¿¿Clinical Review 62 Laboratory Asse...
Document
IPR2016-01332, No. 2052-59 Exhibit - JSN 2052 Grinspoon and Biller, ¿¿¿Clinical Review 62 Laboratory Assessment of Adrenal Insufficiency,¿¿¿ (P.T.A.B. Mar. 8, 2017)
|
|
Cite Document
2071 Exhibit: JSN 2071 Ryan et al, ¿¿¿Abiraterone acetate plus prednisone versus p...
Document
IPR2016-01332, No. 2071-78 Exhibit - JSN 2071 Ryan et al, ¿¿¿Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy naive men with metastatic castration resista...
|
|
Cite Document
